SciBase: Germany shines and financing sorted - Redeye

Redeye saw a Q1 report that was slightly weaker than expected but not a material deviation. The German market continues to develop well and is profitable. The US delayed Medicare fee schedule review affected sales negatively in the quarter, but this issue has now been resolved. We have made small adjustments to our estimates and left our fair value range and Base case unchanged. With the financing sorted, the focus is now on the company's performance in the coming quarter.

Länk till analysen i sin helhet: https://www.redeye.se/research/905785/scibase-germany-shines-and-financing-sorted?utm_source=finwire&utm_medium=RSS